Skip to main content

Advertisement

Log in

Treatment of Central Sensitization in Patients With Rheumatoid Arthritis: a Narrative Overview

  • Pain in Rheumatology (W Nielson, Section Editor)
  • Published:
Current Treatment Options in Rheumatology Aims and scope Submit manuscript

Abstract

Purpose of review

Central sensitization (CS) is present in a variety of chronic pain conditions including rheumatoid arthritis (RA). An overview of the treatment options for desensitizing the central nervous system in RA patients, with CS as their dominant pain mechanism, is provided.

Recent findings

The treatment of pain in RA patients has mostly focused on treating inflammation to indirectly treat pain. Unfortunately, little research has focused on treating CS, which appears to be present in some patients with RA.

Summary

“Treating the brain without ignoring the joints” should be the leading principle in the management of CS in RA patients. Pain neuroscience education, graded activity, and a time-contingent exercise approach are important interventions to implement in clinical practice. Further research is necessary to evaluate the effectiveness of these promising treatments for diminishing hyperexcitability of the central nervous system in RA patients with CS as their dominant pain mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.

    Article  CAS  PubMed  Google Scholar 

  2. Wan SW, He H-G, Mak A, Lahiri M, Luo N, Cheung PP, et al. Health-related quality of life and its predictors among patients with rheumatoid arthritis. Appl Nurs Res. 2016;30:176–83.

    Article  PubMed  Google Scholar 

  3. Furu M, Hashimoto M, Ito H, Fujii T, Terao C, Yamakawa N, et al. Discordance and accordance between patient’s and physician’s assessments in rheumatoid arthritis. Scand J Rheumatol. 2014;43:291–5.

    Article  CAS  PubMed  Google Scholar 

  4. Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum. 2012;64:2814–23.

    Article  PubMed  Google Scholar 

  5. Zhang A, Lee YC. Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization. Curr Osteoporos Rep. 2018;16:603–10.

    Article  PubMed  Google Scholar 

  6. Koop SMW, ten Klooster PM, Vonkeman HE, Steunebrink LMM, van de Laar MAFJ. Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther. 2015;17:237. https://doi.org/10.1186/s13075-015-0761-8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Boyden SD, Hossain IN, Wohlfahrt A, Lee YC. Non-inflammatory causes of pain in patients with rheumatoid arthritis. Curr Rheumatol Rep. 2016;18:30.

    Article  CAS  PubMed  Google Scholar 

  8. Meeus M, Vervisch S, De Clerck LS, Moorkens G, Hans G, Nijs J. Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2012;41:556–67.

    Article  PubMed  Google Scholar 

  9. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994;37:965–82.

    Article  CAS  PubMed  Google Scholar 

  10. Hummel T, Schiessl C, Wendler J, Kobal G. Peripheral and central nervous changes in patients with rheumatoid arthritis in response to repetitive painful stimulation. Int J Psychophysiol. 2000;37:177–83.

    Article  CAS  PubMed  Google Scholar 

  11. Wendler J, Hummel T, Reissinger M, Manger B, Pauli E, Kalden JR, et al. Patients with rheumatoid arthritis adapt differently to repetitive painful stimuli compared to healthy controls. J Clin Neurosci. 2001;8:272–7.

    Article  CAS  PubMed  Google Scholar 

  12. García-Fernández E, Godoy-Izquierdo D, Pérez-García M, Jiménez-Alonso J, López-Chicheri I, Godoy JF. Differences in pressure-pain threshold between healthy women and patients with fibromyalgia syndrome, systemic lupus erythematosus, and rheumatoid arthritis. J Musculoskelet Pain. 2009;17:139–54.

    Article  Google Scholar 

  13. Dhondt T, Willaeys LA, Verbruggen W. Pain threshold in patients with rheumatoid arthritis and effect of manual oscillations. Scand J Rheumatol. 1999;28:88–93.

    Article  CAS  PubMed  Google Scholar 

  14. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895–926.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–15.

    Article  PubMed  Google Scholar 

  16. Leffler A-S, Kosek E, Lerndal T, Nordmark B, Hansson P. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain. 2002;6:161–76.

    Article  PubMed  Google Scholar 

  17. Edwards RR, Wasan AD, Bingham CO, Bathon J, Haythornthwaite JA, Smith MT, et al. Enhanced reactivity to pain in patients with rheumatoid arthritis. Arthritis Res Ther. 2009;11:R61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lee YC, Lu B, Edwards RR, Wasan AD, Nassikas NJ, Clauw DJ, et al. The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum. 2013;65:59–68.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vladimirova N, Jespersen A, Bartels EM, Christensen AW, Bliddal H, Danneskiold-Samsøe B. Pain sensitisation in women with active rheumatoid arthritis: a comparative cross-sectional study. Arthritis. 2015;2015:1–5. https://doi.org/10.1155/2015/434109.

    Article  Google Scholar 

  20. Meeus M, Ickmans K, Struyf F, Hermans L, Noesel KV, Oderkerk J, et al. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial. Pain Physician. 2013 Apr;16(2):E61–70.

  21. Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011;7:216–24.

    Article  CAS  PubMed  Google Scholar 

  22. Bagnato G, De Andres I, Sorbara S, Verduci E, Corallo G, Ferrera A, et al. Pain threshold and intensity in rheumatic patients: correlations with the Hamilton Depression Rating scale. Clin Rheumatol. 2015;34:555–61.

    Article  PubMed  Google Scholar 

  23. Zyrianova Y, Kelly BD, Gallagher C, McCarthy C, Molloy MG, Sheehan J, et al. Depression and anxiety in rheumatoid arthritis: the role of perceived social support. Ir J Med Sci. 2006;175:32–6.

    Article  CAS  PubMed  Google Scholar 

  24. Rifbjerg-Madsen S, Christensen AW, Boesen M, Christensen R, Danneskiold-Samsøe B, Bliddal H, et al. The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study. Arthritis Res Ther. 2018;20:105. https://doi.org/10.1186/s13075-018-1581-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther. 2011;13:R83.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Biobehav Res. 2018;23:e12137.

    Article  Google Scholar 

  27. Curatolo M. Diagnosis of altered central pain processing. Spine. 2011;36:S200–4.

    Article  PubMed  Google Scholar 

  28. Arendt-Nielsen L, Egsgaard LL, Petersen KK, Eskehave TN, Nielsen TG, Hoeck HC, et al. A mechanism-based pain sensitivity index to characterize knee osteoarthritis patients with different disease stages and pain levels. Eur J Pain. 2015;19:1406–17.

    Article  CAS  PubMed  Google Scholar 

  29. Neogi T, Frey-Law L, Scholz J, Niu J, Arendt-Nielsen L, Woolf C, et al. Sensitivity and sensitisation in relation to pain severity in knee osteoarthritis: trait or state? Ann Rheum Dis. 2015;74:682–8.

    Article  PubMed  Google Scholar 

  30. Nijs J, Torres-Cueco R, van Wilgen CP, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17:447–57.

    PubMed  Google Scholar 

  31. Wasserman A. Diagnosis and Management of Rheumatoid Arthritis. AFP. 2011;84:1245–52.

    Google Scholar 

  32. Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care. 2018;45:237–55.

    Article  PubMed  Google Scholar 

  33. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol. 2004;31:695–700.

    PubMed  Google Scholar 

  34. Kolski M, O’Connor A. A world of hurt: a guide to classifying pain. St Louis: Thomasland Publishers, Inc; 2015.

    Google Scholar 

  35. Neblett R, Cohen H, Choi Y, Hartzell M, Williams M, Mayer TG, et al. The central sensitization inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sampje. J Pain. 2013;14:438–45.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kregel J, Schumacher C, Dolphens M, Malfliet A, Goubert D, Lenoir D, et al. Convergent validity of the Dutch Central Sensitization Inventory: associations with psychophysical pain measures, quality of life, disability, and pain cognitions in patients with chronic spinal pain. Pain Pract. 2018;18:777–87.

    Article  PubMed  Google Scholar 

  37. Nijs J, Van Houdenhove B, Oostendorp RAB. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Man Ther. 2010;15:135–41.

    Article  PubMed  Google Scholar 

  38. Steiman AJ, Pope JE, Thiessen-Philbrook H, Li L, Barnabe C, Kalache F, et al. Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. Rheumatol Int. 2013;33:1105–20.

    Article  CAS  PubMed  Google Scholar 

  39. McWilliams DF, Zhang W, Mansell JS, Kiely PDW, Young A, Walsh DA. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res (Hoboken). 2012;64:1505–13.

    Article  Google Scholar 

  40. Altawil R, Saevarsdottir S, Wedrén S, Alfredsson L, Klareskog L, Lampa J. Remaining pain in early rheumatoid arthritis patients treated with methotrexate. Arthritis Care Res (Hoboken). 2016;68:1061–8.

    Article  CAS  Google Scholar 

  41. Geenen R, Overman CL, Christensen R, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77:797–807. https://doi.org/10.1136/annrheumdis-2017-212662.

    Article  PubMed  Google Scholar 

  42. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524–32.

    Article  Google Scholar 

  43. Goubert L, Crombez G, Van Damme S, Vlaeyen JWS, Bijttebier P, Roelofs J. Confirmatory factor analysis of the Tampa Scale for Kinesiophobia: invariant two-factor model across low back pain patients and fibromyalgia patients. Clin J Pain. 2004;20:103–10.

    Article  PubMed  Google Scholar 

  44. Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain. 2007;11:153–63.

    Article  PubMed  Google Scholar 

  45. Courtney CA, Kavchak AE, Lowry CD, O’Hearn MA. Interpreting joint pain: quantitative sensory testing in musculoskeletal management. J Orthop Sports Phys Ther. 2010;40:818–25.

    Article  PubMed  Google Scholar 

  46. Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B, Wylde V, et al. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil. 2012;20:1075–85.

    Article  CAS  PubMed  Google Scholar 

  47. Arendt-Nielsen L, Skou ST, Nielsen TA, Petersen KK. Altered central sensitization and pain modulation in the CNS in chronic joint pain. Curr Osteoporos Rep. 2015;13:225–34.

    Article  PubMed  Google Scholar 

  48. Hendiani JA, Westlund KN, Lawand N, Goel N, Lisse J, McNearney T. Mechanical sensation and pain thresholds in patients with chronic arthropathies. J Pain. 2003;4:203–11.

    Article  PubMed  Google Scholar 

  49. Maxwell S, Sterling M. An investigation of the use of a numeric pain rating scale with ice application to the neck to determine cold hyperalgesia. Man Ther. 2013;18:172–4.

    Article  PubMed  Google Scholar 

  50. Neogi T, Guermazi A, Roemer F, Nevitt MC, Scholz J, Arendt-Nielsen L, et al. Association of joint inflammation with pain sensitization in knee osteoarthritis. Arthritis Rheumatol. 2016;68:654–61.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Nijs J, Malfliet A, Ickmans K, Baert I, Meeus M. Treatment of central sensitization in patients with ‘unexplained’ chronic pain: an update. Expert Opin Pharmacother. 2014;15:1671–83.

    Article  CAS  PubMed  Google Scholar 

  52. Lee YC, Massarotti E, Edwards RR, Lu B, Liu C, Lo Y, et al. The effect of milnacipran on pain in rheumatoid arthritis patients with widespread pain: a randomized blinded crossover trial. J Rheumatol. 2016;43:38–45.

    Article  CAS  PubMed  Google Scholar 

  53. Ormseth MJ, Eyler AE, Hammonds CL, Boomershine CS. Milnacipran for the management of fibromyalgia syndrome. J Pain Res. 2010;3:15–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398–409.

    Article  CAS  PubMed  Google Scholar 

  55. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30:1988–2004.

    Article  CAS  PubMed  Google Scholar 

  56. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100:213–7.

    Article  CAS  PubMed  Google Scholar 

  57. Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIS) for fibromyalgia. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD010292.pub2.

  58. Sluka K. Mechanisms and management of pain for the physical therapist. 2nd ed. Philadelphia: Wolters Kluwer Health; 2016.

    Google Scholar 

  59. Lluch Girbés E, Meeus M, Baert I, Nijs J. Balancing “hands-on” with “hands-off” physical therapy interventions for the treatment of central sensitization pain in osteoarthritis. Man Ther. 2015;20:349–52.

    Article  PubMed  Google Scholar 

  60. Oosterwijck JV, Meeus M, Paul L, Schryver MD, Pascal A, Lambrecht L, et al. Pain physiology education improves health status and endogenous pain inhibition in fibromyalgia. Clin J Pain. 2013;29:873–82.

    Article  PubMed  Google Scholar 

  61. Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011;92:2041–56.

    Article  PubMed  Google Scholar 

  62. Butler D, Moseley GL. Explain Pain, 2nd ed. Adelaide, Australia, Noigroup Publications. 2013

  63. Nijs J, Paul van Wilgen C, Van Oosterwijck J, van Ittersum M, Meeus M. How to explain central sensitization to patients with ‘unexplained’ chronic musculoskeletal pain: practice guidelines. Man Ther. 2011;16:413–8.

    Article  PubMed  Google Scholar 

  64. McWilliams DF, Walsh DA. Pain mechanisms in rheumatoid arthritis. Clin Exp Rheumatol. 2017 Oct;35 Suppl 107(5):94–101.

  65. Meeus M, Hermans L, Ickmans K, Struyf F, van Cauwenbergh D, Bronckaerts L, et al. Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: a double-blind randomized controlled trial. Pain Pract. 2015;15:98–106.

    Article  PubMed  Google Scholar 

  66. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85:317–32.

    Article  CAS  PubMed  Google Scholar 

  67. Arendt-Nielsen L, and Perrot S. (2017). Pain in the joints. 1st ed. Philadelphia: Wolters Kluwer.

  68. Park Y, Chang M. Effects of rehabilitation for pain relief in patients with rheumatoid arthritis: a systematic review. J Phys Ther Sci. 2016;28:304–8.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Ye L, Kalichman L, Spittle A, Dobson F, Bennell K. Effects of rehabilitative interventions on pain, function and physical impairments in people with hand osteoarthritis: a systematic review. Arthritis Res Ther. 2011;13:R28.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Vliet Vlieland TPM, van den Ende CH. Nonpharmacological treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2011;23:259–64.

    Article  PubMed  Google Scholar 

  71. Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. The role of exercise in the management of rheumatoid arthritis. Expert Rev Clin Immunol. 2015;11:1121–30.

    Article  CAS  PubMed  Google Scholar 

  72. Hurkmans E, van der Giesen F, Vliet Vlieland T, Schoones J and Van den Ende E. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database of Systematic Reviews. 2009

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Meeus PT, PhD.

Ethics declarations

Conflict of Interest

L. Meert declares that she has no conflict of interest. R. J. E. M. Smeets declares that he has no conflict of interest. I. Baert declares that she has no conflict of interest. M. Mertens declares that he has no conflict of interest. A. Boonen declares that she has no conflict of interest. M. Meeus declares that she has no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pain in Rheumatology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meert, L., Smeets, R.J.E.M., Baert, I. et al. Treatment of Central Sensitization in Patients With Rheumatoid Arthritis: a Narrative Overview. Curr Treat Options in Rheum 5, 179–189 (2019). https://doi.org/10.1007/s40674-019-00125-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40674-019-00125-x

Keywords

Navigation